Clinical Trial

Modulation of Hyperandrogenic Anovulation Through Fenugreek Seeds

Completed
View on ClinicalTrials.gov →
Summary
Hyperandrogenic anovulation is a common gynecological illness that impacts the ovaries, vagina and uterus. According to Statistics, in Pakistan 17.6% of individuals seeking treatment at infertility clinics were found to be affected by hyperandrogenic anovulation. Studies indicate that fenugreek seeds have the potential to improve insulin sensitivity, control hormone levels, namely the increased androgens linked to hyperandrogenic anovulation, and promote ovulation, a process commonly interrupted in individuals with hyperandrogenic anovulation. In order to create a therapy plan that is both affordable and easily accessible for women who suffer from hyperandrogenic anovulation, this study aims to determine the therapeutic efficacy of fenugreek seed powder in reducing symptoms related to the illness. Furthermore, it aims to increase knowledge on the extensive utilization of fenugreek seed powder as a natural treatment for hyperandrogenic anovulation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-08.
Trial Details
NCT Number NCT07586969
Lead Sponsor University of Lahore
Conditions Poly Cystic Ovary Syndrome
Enrollment 70 participants
Start Date 2024-09-11
Primary Completion 2024-11-11 (estimated)
Study Completion 2024-12-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-28